| Professional Services Industry | Industrials Sector | Dr. Richard Charles Henshaw M.D. CEO | XFRA Exchange | AU000000MVF3 ISIN |
| US Country | 892 Employees | 4 Mar 2026 Last Dividend | 28 Apr 2020 Last Split | - IPO Date |
Monash IVF Group Limited is a distinguished healthcare provider specializing in assisted reproductive technologies and specialist women imaging services, with operations spanning across Australia and Malaysia. Established in the year 2014 and headquartered in Cremorne, Australia, the organization is committed to delivering high quality fertility treatment and diagnostic services.Adopting a comprehensive approach to reproductive health, Monash IVF Group is at the forefront of offering innovative solutions and support for individuals and couples navigating the complexities of fertility issues.
This service encompasses the use of high-frequency sound waves to create images of the internal structures of the pelvic region, including the uterus, ovaries, and early stages of pregnancy. It is instrumental in assessing and diagnosing various conditions related to women's health and pregnancy.
Monash IVF Group Limited provides a comprehensive range of fertility treatments, including but not limited to in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), and egg-freezing services. These treatments are designed to assist individuals and couples in achieving pregnancy, offering hope to those facing challenges in conceiving naturally.
These services are focused on the early detection and diagnosis of fetal abnormalities, genetic conditions, and other pregnancy-related issues. Utilizing advanced technologies and methodologies, Monash IVF Group Limited helps to ensure the health and well-being of both the mother and the fetus during pregnancy.
As a key component of its fertility treatment services, Monash IVF Group Limited specializes in IVF treatments, offering a highly effective solution for couples struggling with infertility. This process involves fertilizing an egg outside the body and implanting the embryo back into the womb, significantly increasing the chances of conception.